NFAT as a Biomarker and Therapeutic Target in Non–Small Cell Lung Cancer–Related Brain Metastasis

NFAT as a Biomarker and Therapeutic Target in Non–Small Cell Lung Cancer–Related Brain Metastasis

BackgroundBrain metastases (BMs) are associated with poor prognosis and significant mortality, and approximately 25% of patients with non–small cell lung cancer (NSCLC) develop BMs. The present study was aimed to understand the relationships between BM and NSCLC and reveal potential biomarkers and t...

Full description

Bibliographic Details
Main Authors: Lu Peng, Yihao Tao, Rui Wu, Jing Su, Maoyuan Sun, Yuan Cheng, Zongyi Xie, Jinning Mao, Xiaohui Zhan, Guodong Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Oncology
Subjects:
non–small cell lung cancer
brain metastasis
biomarker
bioinformatics
immunohistochemistry
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.781150/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.781150/full

Similar Items